LICENSE AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN AMGEN INC. AND INTERMUNE, INC. June 15, 2001License and Commercialization Agreement • August 3rd, 2001 • Intermune Inc • Pharmaceutical preparations • California
This License and Commercialization Agreement (the "Agreement") is made effective as of the 15th day of June, 2001 (the "Effective Date") by and between Amgen Inc., a Delaware corporation having its principal place of business at One Amgen Center Drive, Thousand Oaks, CA 91320-1799 ("Amgen") and InterMune, Inc., a Delaware corporation having its principal place of business at 1710 Gilbreth Road, Suite 310, Burlingame, CA 94010-1317 ("InterMune"). Amgen and InterMune are sometimes referred to herein individually as a "Party" and collectively as the "Parties", and references to "InterMune" and "Amgen" shall include their respective Affiliates.
